Clinical trial
Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee…
NCT00041756 · Procter and Gamble, Industry · Completed
Key facts
| NCT number | NCT00041756 |
|---|---|
| Title | Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee Osteoarthritis |
| Official title | Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee Osteoarthritis |
| Lead sponsor | Procter and Gamble, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoarthritis, Knee |
| Intervention type | Drug |
| Interventions | PG-530742, Placebo, 50 mg PG-530742, 100 mg PG-530742, 200 mg PG-530742 |
| Enrollment | 395 |
| Start date | Jul 1, 2002 |
| Primary completion | Feb 1, 2004 |
| Completion | Feb 1, 2004 |
| First posted | Jul 17, 2002 |
| Last update posted | Nov 8, 2011 |
| Countries | Hungary, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: